Learn More
Medchemexpress LLC 4-[(3,5-diamino-1H-pyrazol-4-yl)azo]-phenol | 140651-18-9 | MFCD09262258 | 99.6% | 218.22 g/mol | C9H10N6O | 50 MG

Supplier: Medchemexpress LLC HY10042950MG
CAN508 is a potent, ATP-competitive inhibitor of cyclin-dependent kinase 9 (CDK9)/cyclin T1 intended for research use. It inhibits CDK9/cyclin T1 with an IC50 of 0.35 μM, displays ~38-fold selectivity over other CDK/cyclin complexes, and has demonstrated antitumor activity in preclinical studies.
- Potent ATP-competitive inhibitor of CDK9/cyclin T1 (IC50 0.35 μM).
- Approximately 38-fold selectivity versus other CDK/cyclin complexes.
- Reported antitumor activity in preclinical models.
- High purity, 99.6%.
- Molecular weight 218.22 g/mol; formula C9H10N6O.
- Supplied with supporting documentation such as SDS, COA, and LCMS.
- Intended for research use only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.